• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.

作者信息

Bourdette D N, Prochazka A V, Mitchell W, Licari P, Burks J

机构信息

Department of Neurology, Portland VA Medical Center, OR 97207.

出版信息

Arch Phys Med Rehabil. 1993 Jan;74(1):26-31.

PMID:8420515
Abstract

We retrospectively determined health care costs among veterans with multiple sclerosis (MS) and correlated the costs with neurologic dysfunction. Total health care costs for the 165 patients averaged $35,000/year. VA benefits and homecare together accounted for 85% of the total costs. Total health care costs correlated with two measures of neurologic dysfunction, the Expanded Disability Status Scale (EDSS) (r = 0.61, p < 0.001) and the Incapacity Status Scale (ISS) (r = 0.64, p < 0.001). The costs of VA benefits, homecare, and hospitalizations also correlated with the EDSS, ISS, and other measures of neurologic dysfunction whereas the cost of outpatient clinic visits did not. In a period of three years, there were 40 hospitalizations, at a total cost of $412,800, that were potentially preventable with appropriate outpatient management. Improving selfcare and avoiding preventable hospitalizations might lower the considerable health care costs of MS.

摘要

相似文献

1
Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.
Arch Phys Med Rehabil. 1993 Jan;74(1):26-31.
2
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.量化美国多发性硬化症患者残疾加剧与医疗资源利用、生活质量、工作生产力、医疗成本之间的关系。
BMC Health Serv Res. 2016 Jul 22;16:294. doi: 10.1186/s12913-016-1532-1.
3
Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.Kurtkze 扩展残疾状况量表与功能独立性测量的比较:多发性硬化症相关残疾的测量。
Disabil Rehabil. 2013;35(22):1877-84. doi: 10.3109/09638288.2013.766269. Epub 2013 Apr 19.
4
Direct and indirect economic consequences of multiple sclerosis in Ireland.爱尔兰多发性硬化症的直接和间接经济后果。
Appl Health Econ Health Policy. 2014 Dec;12(6):635-45. doi: 10.1007/s40258-014-0128-3.
5
Cost of multiple sclerosis in the Czech Republic: the COMS study.捷克共和国多发性硬化症的成本:COMS 研究。
Mult Scler. 2012 May;18(5):662-8. doi: 10.1177/1352458511424422. Epub 2011 Sep 30.
6
Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group.多发性硬化症的疾病负担:第一部分:疾病成本。加拿大疾病负担研究小组。
Can J Neurol Sci. 1998 Feb;25(1):23-30. doi: 10.1017/s0317167100033448.
7
Costs and quality of life of multiple sclerosis in Switzerland.瑞士多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S86-95. doi: 10.1007/s10198-006-0383-9.
8
Demographic, socioeconomic and clinical correlates of self-management in multiple sclerosis.多发性硬化症自我管理的人口统计学、社会经济和临床相关因素
Disabil Rehabil. 2015;37(21):1970-5. doi: 10.3109/09638288.2014.993435. Epub 2015 Jul 25.
9
Costs and quality of life of multiple sclerosis in Austria.奥地利多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S14-23. doi: 10.1007/s10198-006-0382-x.
10
Costs and quality of life for patients with multiple sclerosis in Belgium.比利时多发性硬化症患者的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S24-33. doi: 10.1007/s10198-006-0377-7.

引用本文的文献

1
Development of a Job Retention Vocational Rehabilitation Intervention for People with Multiple Sclerosis Following the Person-Based Approach.基于人本主义方法为多发性硬化症患者开发的工作保留职业康复干预措施。
Clin Rehabil. 2024 Jul;38(7):965-978. doi: 10.1177/02692155241235956. Epub 2024 Feb 28.
2
Triaging Patients with Multiple Sclerosis in the Emergency Department: Room for Improvement.急诊科对多发性硬化症患者的分诊:仍有改进空间。
Int J MS Care. 2017 Nov-Dec;19(6):290-296. doi: 10.7224/1537-2073.2016-069.
3
Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany.
德国多发性硬化症患者在开始使用那他珠单抗之前和之后的医疗资源利用情况。
Clinicoecon Outcomes Res. 2017 Feb 1;9:85-97. doi: 10.2147/CEOR.S117962. eCollection 2017.
4
Cost of Illness of Multiple Sclerosis - A Systematic Review.多发性硬化症的疾病成本——一项系统综述
PLoS One. 2016 Jul 13;11(7):e0159129. doi: 10.1371/journal.pone.0159129. eCollection 2016.
5
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.美国多发性硬化症患者使用那他珠单抗前后的医疗资源利用情况。
Clinicoecon Outcomes Res. 2013 Dec 19;6:11-20. doi: 10.2147/CEOR.S55779. eCollection 2013.
6
Prescribing recommendations for interferon-Beta in multiple sclerosis.多发性硬化症中干扰素-β的处方建议。
CNS Drugs. 1997 Aug;8(2):102-12. doi: 10.2165/00023210-199708020-00002.
7
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.主要研究终点:复发缓解型多发性硬化症中依那西普的附加疗效。
J Neurol. 2012 May;259(5):898-905. doi: 10.1007/s00415-011-6275-7. Epub 2011 Oct 19.
8
The direct cost of patients with multiple sclerosis: a survey from Italian MS centres.多发性硬化症患者的直接成本:来自意大利多发性硬化症中心的调查。
Neurol Sci. 2011 Dec;32(6):1035-41. doi: 10.1007/s10072-011-0578-4. Epub 2011 Apr 20.
9
Multiple sclerosis in Italy: cost-of-illness study.意大利多发性硬化症:疾病成本研究。
Neurol Sci. 2011 Oct;32(5):787-94. doi: 10.1007/s10072-011-0499-2. Epub 2011 Mar 16.
10
The cost of multiple sclerosis in Norway.挪威多发性硬化症的成本。
Eur J Health Econ. 2012 Feb;13(1):81-91. doi: 10.1007/s10198-010-0286-7. Epub 2010 Nov 16.